Search clinical trials for: CDK4/6 inihibitor,
Total 7058 results
-
Institut für Klinische Krebsforschung IKF GmbH...Recruiting
-
Eli Lilly and CompanyCompletedMetastatic Castration-Resistant Prostate CancerFrance, United States, Spain
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
Hunan Cancer HospitalNot yet recruitingBreast Cancer | Endocrine Therapy | CDK4/6 Inhibitors | Subsequent Treatment
-
Henan Cancer HospitalRecruitingDigestive System TumorsChina
-
Washington University School of MedicineBiovicaNot yet recruitingMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Zhejiang Cancer HospitalRecruitingAdvanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment FailedChina
-
RenJi HospitalRecruiting
-
Eli Lilly and CompanyCompletedMetastatic Cancer | Advanced CancerChina
-
Shanghai Pharma Biotherapeutics USA Inc.RecruitingLiposarcoma, DedifferentiatedUnited States
-
Yonsei UniversityActive, not recruiting
-
G1 Therapeutics, Inc.TerminatedSmall Cell Lung CancerUnited States, Croatia, Belgium, Slovakia, Bosnia and Herzegovina, North Macedonia, Serbia, Slovenia
-
Institute of Cancer Research, United KingdomRecruitingBreast Cancer FemaleUnited Kingdom
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
University of Texas Southwestern Medical CenterActive, not recruitingAbemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6Glioblastoma | Brain Tumor | GBM | Brain Tumor, RecurrentUnited States
-
Namik Kemal UniversityNot yet recruitingCan the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 InhibitorsTurkey
-
Taixing People's HospitalRecruiting
-
Novartis PharmaceuticalsCompletedTumors With CDK4/6 Pathway ActivationUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Completed
-
Erasmus Medical CenterActive, not recruiting
-
American Society of Clinical OncologyPatient-Centered Outcomes Research InstituteNot yet recruitingMetastatic Breast Cancer
-
European Organisation for Research and Treatment...Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI... and other collaboratorsActive, not recruitingBreast Cancer Stage II | Breast Cancer Stage IIISpain, France, Italy, Belgium, Jordan, Poland, Germany, United Kingdom, Portugal
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Safeway FoundationRecruiting
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
The Methodist Hospital Research InstituteEli Lilly and CompanyRecruitingHER2-negative Breast Cancer | ER-Positive Breast CancerUnited States
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Sunnybrook Health Sciences CentreRecruitingMetastatic Breast CancerCanada
-
Centre Francois BaclesseActive, not recruitingBreast Cancer | Metastatic Breast CancerFrance
-
Shengjing HospitalActive, not recruiting
-
Saint Petersburg State Budgetary Healthcare Institution...Active, not recruitingThe Neoadjuvant TherapyRussian Federation
-
National Cancer Institute (NCI)Recruiting
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Guatemala, H...
-
Istituto Scientifico Romagnolo per lo Studio e...Agenzia Italiana del FarmacoUnknownMetastatic Breast Cancer | Hormone Receptor Positive Breast Cancer | Hormone Receptor Negative Breast CancerItaly
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
University of HohenheimUniversität TübingenCompletedSafety of Native vs. Micellar 6-PN After Oral Intake | Pharmacokinetics of Native vs. Micellar 6-PN After Oral Intake | PBMC Activity After Native vs. Micellar 6-PN Oral IntakeGermany
-
Institut Paoli-CalmettesMerck KGaA, Darmstadt, Germany; National Cancer Institute, FranceNot yet recruiting
-
University Hospital HeidelbergCompleted
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminated
-
biotx.ai GmbHWithdrawn
-
Novartis PharmaceuticalsTerminatedEarly Breast CancerSpain, Singapore, United States
-
University of VirginiaNovartis PharmaceuticalsUnknownGlioma | GlioblastomaUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingHR+/HER2- Advanced and/or Metastatic Breast Cancer
-
Novartis PharmaceuticalsCompletedTeratomaSpain, Netherlands, United States, France
-
Dartmouth-Hitchcock Medical CenterRecruitingAdvanced Breast CancerUnited States
-
Fondazione Sandro PitiglianiClinical Research Technology S.r.l.RecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerItaly
-
Yonsei UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | PostmenopausalKorea, Republic of